- --------------------------------------------------------------------------------
FORM 3
- --------------------------------------------------------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding
Company Act of 1935 or Section 30(f) of
the Investment Company Act of 1940
- -------------------------------------
OMB Approval
- -------------------------------------
OMB Number: 3235-0104
Expires: September 30, 1998
Estimated average burden
hours per response.........0.5
- -------------------------------------
- --------------------------------------------------------------------------------
(Print or Type Responses)
1. Name and Address of Reporting Person*
SHERRIS, David
----------------------------------------------------------------
(Last) (First) (Middle)
c/o OXiGENE, INC.
One Copley Place, Suite 602
----------------------------------------------------------------
(Street)
Boston, MA 02116
----------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
6/9/98
3. IRS or Social Security Number of Reporting Person
(Voluntary)
4. Issuer name and Ticker or Trading Symbol
OXiGENE, Inc. - OXGN
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
-- Director
-- 10% Owner
X- Officer (give title below)
-- Other (specify below)
Chief Operating Officer
and Director of Drug
Development
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing
(Check applicable Line)
X Form Filed by One Reporting Person
Form Filed by More than One Reporting Person
Table I Non-Derivative Securities Beneficially Owned
1. Title of Security 2. Amount of 3. Ownership 4. Nature of Indirect
(Instr. 4) Securities Form: Direct Beneficial
Beneficially (D) or Indirect Ownership
Owned (I) (Instr. 5) (Instr. 5)
(Instr. 4)
<TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction
5(b)(v).
<CAPTION>
Table II-- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C>
1. Title of 2. Date Exer- 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature of
Derivative cisable and Securities Underlying sion or ship Form Indirect
Security Expiration Derivative Security Exercise of Deriv- Beneficial
(Instr. 4) Date (Instr. 4) Price of ative Ownership
(Month/Day/Year) Deri- Security: (Instr. 5)
vative Direct (D) or
Security Indirect (I)
(Instr. 5)
</TABLE>
<TABLE>
<S> <C> <C> <C> <C> <C> <C>
Date Expira- Title Amount or
Exer- tion Number of
cisable Date Shares
Non-Qualified
Stock Options (1) 6/9/2008 Common Stock 45,000 $12.00 D
</TABLE>
Explanation of Responses:
(1) Options vest in 3 equal cumulative installments on each of June 9, 1999,
2000 and 2001.
**Intentional mistatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space is insufficient, see Instruction 6 for procedure
/s/ David Sherris
- --------------------
David Sherris, Ph.D.
November 2, 1998
Date